2-1791974-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BS2

The NM_001303052.2(MYT1L):​c.3454G>A​(p.Val1152Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000344 in 1,453,932 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1152L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

MYT1L
NM_001303052.2 missense

Scores

8
8
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.82

Publications

0 publications found
Variant links:
Genes affected
MYT1L (HGNC:7623): (myelin transcription factor 1 like) This gene encodes a member of the zinc finger superfamily of transcription factors whose expression, thus far, has been found only in neuronal tissues. The encoded protein belongs to a novel class of cystein-cystein-histidine-cystein zinc finger proteins that function in the developing mammalian central nervous system. Forced expression of this gene in combination with the basic helix-loop-helix transcription factor NeuroD1 and the transcription factors POU class 3 homeobox 2 and achaete-scute family basic helix-loop-helix transcription factor 1 can convert fetal and postnatal human fibroblasts into induced neuronal cells, which are able to generate action potentials. Mutations in this gene have been associated with an autosomal dominant form of cognitive disability and with autism spectrum disorder. Alternative splicing results in multiple variants. [provided by RefSeq, Jul 2017]
MYT1L Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 39
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • syndromic complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BS2
High AC in GnomAdExome4 at 5 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001303052.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYT1L
NM_001303052.2
MANE Select
c.3454G>Ap.Val1152Met
missense
Exon 25 of 25NP_001289981.1Q9UL68-1
MYT1L
NM_001329844.2
c.3454G>Ap.Val1152Met
missense
Exon 26 of 26NP_001316773.1Q9UL68-1
MYT1L
NM_001329845.1
c.3454G>Ap.Val1152Met
missense
Exon 25 of 25NP_001316774.1Q9UL68-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYT1L
ENST00000647738.2
MANE Select
c.3454G>Ap.Val1152Met
missense
Exon 25 of 25ENSP00000497479.2Q9UL68-1
MYT1L
ENST00000428368.7
TSL:1
c.3454G>Ap.Val1152Met
missense
Exon 26 of 26ENSP00000396103.3Q9UL68-1
MYT1L
ENST00000399161.8
TSL:1
c.3448G>Ap.Val1150Met
missense
Exon 25 of 25ENSP00000382114.3Q9UL68-4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000419
AC:
1
AN:
238510
AF XY:
0.00000773
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000344
AC:
5
AN:
1453932
Hom.:
0
Cov.:
30
AF XY:
0.00000553
AC XY:
4
AN XY:
722792
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33142
American (AMR)
AF:
0.00
AC:
0
AN:
42756
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25852
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39638
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
83866
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53296
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5748
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1109508
Other (OTH)
AF:
0.00
AC:
0
AN:
60126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000468
Hom.:
0
ExAC
AF:
0.00000828
AC:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.24
T
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.89
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Benign
0.013
T
MetaRNN
Uncertain
0.69
D
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
7.8
PrimateAI
Pathogenic
0.90
D
PROVEAN
Uncertain
-2.6
D
REVEL
Uncertain
0.33
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.012
D
Polyphen
1.0
D
Vest4
0.63
MutPred
0.32
Gain of disorder (P = 0.0795)
MVP
0.75
MPC
2.1
ClinPred
0.96
D
GERP RS
5.9
Varity_R
0.54
gMVP
0.96
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs774825001; hg19: chr2-1795746; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.